Georgakis S, Ioannidou K, Mora B, Orfanakis M, Brenna C, Muller Y
Front Immunol. 2025; 16:1530327.
PMID: 40070830
PMC: 11894538.
DOI: 10.3389/fimmu.2025.1530327.
Ryback A, Cowan G
Front Immunol. 2025; 16:1489312.
PMID: 40034707
PMC: 11872726.
DOI: 10.3389/fimmu.2025.1489312.
Felixberger P, Andrieux G, Maul-Pavicic A, Goldacker S, Harder I, Gutenberger S
Front Immunol. 2025; 16:1512279.
PMID: 40013136
PMC: 11861550.
DOI: 10.3389/fimmu.2025.1512279.
Sasaki T, Sowerby J, Xiao Y, Wang R, Marks K, Horisberger A
bioRxiv. 2025; .
PMID: 39974998
PMC: 11838332.
DOI: 10.1101/2025.01.27.635189.
Bentham R, Jones T, Black J, Martinez-Ruiz C, Dietzen M, Litovchenko M
Nat Genet. 2025; 57(3):694-705.
PMID: 39966644
PMC: 11906351.
DOI: 10.1038/s41588-025-02086-5.
TCL1A in naïve B cells as a therapeutic target for type 1 diabetes.
Luo S, Zhang L, Wei C, Guo C, Meng Z, Zeng H
EBioMedicine. 2025; 113:105593.
PMID: 39946833
PMC: 11872515.
DOI: 10.1016/j.ebiom.2025.105593.
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report.
van Schaik M, Arends E, Wetzels M, Kraaij T, Verbruggen S, van der Kooij S
Lupus Sci Med. 2025; 12(1).
PMID: 39939125
PMC: 11822420.
DOI: 10.1136/lupus-2024-001424.
Signaling Activation and Modulation in Extrafollicular B Cell Responses.
Staniek J, Rizzi M
Immunol Rev. 2025; 330(1):e70004.
PMID: 39917832
PMC: 11803499.
DOI: 10.1111/imr.70004.
Organ-based characterization of B cells in patients with systemic lupus erythematosus.
Wang Y, Zhao R, Liang Q, Ni S, Yang M, Qiu L
Front Immunol. 2025; 16:1509033.
PMID: 39917309
PMC: 11798990.
DOI: 10.3389/fimmu.2025.1509033.
Opportunities and limitations of B cell depletion approaches in SLE.
Stockfelt M, Teng Y, Vital E
Nat Rev Rheumatol. 2025; 21(2):111-126.
PMID: 39815102
DOI: 10.1038/s41584-024-01210-9.
Hypomorphic RAG2 Deficiency Promotes Selection of Self-Reactive B Cells.
Thouvenel C, Tipton C, Yamazaki Y, Zhang T, Rylaarsdam S, Hom J
J Clin Immunol. 2025; 45(1):66.
PMID: 39812873
PMC: 11735530.
DOI: 10.1007/s10875-024-01849-9.
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases.
Brandi R, Paganelli A, DAmelio R, Giuliani P, Lista F, Salemi S
Vaccines (Basel). 2025; 12(12.
PMID: 39772079
PMC: 11680146.
DOI: 10.3390/vaccines12121418.
Applying phylogenetic methods for species delimitation to distinguish B-cell clonal families.
Voss K, Kaur K, Banerjee R, Breden F, Pennell M
Front Immunol. 2024; 15:1505032.
PMID: 39687606
PMC: 11646844.
DOI: 10.3389/fimmu.2024.1505032.
IFN-associated B cell hyperactivity is highly enriched in SLE patients harboring Sm/RNP antibodies.
van Dooren H, Atisha-Fregoso Y, Dorjee A, Huizinga T, Mackay M, Aranow C
bioRxiv. 2024; .
PMID: 39605660
PMC: 11601621.
DOI: 10.1101/2024.11.18.624119.
Association between peripheral activated naive and double negative 2 B-cell subsets and clinical parameters in lupus nephritis patients.
Wangriatisak K, de Vries C, Sharma R, Huang W, Gronwall C, Pisitkun P
Scand J Immunol. 2024; 101(1):e13427.
PMID: 39592449
PMC: 11631828.
DOI: 10.1111/sji.13427.
Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem.
Ataca S, Sangesland M, de Paiva Froes Rocha R, Torrents de la Pena A, Ronsard L, Boyoglu-Barnum S
Cell Rep. 2024; 43(12):114990.
PMID: 39580804
PMC: 11672684.
DOI: 10.1016/j.celrep.2024.114990.
Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19.
Zhu W, Zheng Y, Yu M, Witman N, Zhou L, Wei J
Blood. 2024; .
PMID: 39576992
PMC: 11811936.
DOI: 10.1182/blood.2024025010.
Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid Syndrome.
Dieudonne Y, Lorenzetti R, Rottura J, Janowska I, Frenger Q, Jacquel L
Nat Commun. 2024; 15(1):9921.
PMID: 39548093
PMC: 11568317.
DOI: 10.1038/s41467-024-54228-8.
Machine learning for precision diagnostics of autoimmunity.
Kruta J, Carapito R, Trendelenburg M, Martin T, Rizzi M, Voll R
Sci Rep. 2024; 14(1):27848.
PMID: 39537649
PMC: 11561187.
DOI: 10.1038/s41598-024-76093-7.
Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE.
Faliti C, Van T, Anam F, Cheedarla N, Williams M, Mishra A
Nat Immunol. 2024; 26(1):131-145.
PMID: 39533072
PMC: 11695260.
DOI: 10.1038/s41590-024-02010-9.